General Electric Company logo

General Electric Company (GEOO34)

Market Closed
12 Jun, 19:55
B3 B3
R$
1,677. 35
+14.59
+0.8775%
R$
1.45T Market Cap
6.6 P/E Ratio
6.89% Div Yield
4 Volume
0 Eps
R$ 1,662.76
Previous Close
Add Transaction
Day Range
1,673.64 1,700
Year Range
1,287 1,866.9
Want to track GEOO34 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

GEOO34 closed today higher at R$1,677.35, an increase of 0.8775% from yesterday's close, completing a monthly increase of 18.1682% or R$257.89. Over the past 12 months, GEOO34 stock lost -2.3206%.
GEOO34 pays dividends to its shareholders, with the most recent payment made on May 04, 2026.
The last earnings report, released on Apr 20, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
General Electric Company has completed 1 stock splits, with the recent split occurring on Aug 02, 2021.
The company's stock is traded on one exchange.

GEOO34 Chart

People also search for

Philip Morris International Inc. (Brazilian Depositary Receipt)
R$ 465.67
+3.2963%
PepsiCo, Inc. - Brazilian Depositary Receipt
R$ 48.71
-0.1435%
Fomento Económico Mexicano S.A.B. de C.V.
R$ 620.62
0%
Anheuser-Busch InBev SA/NV BDR
R$ 69.64
-1.2199%
Altria Group Inc.
R$ 347.2
0%

General Electric Company (GEOO34) FAQ

What is the stock price today?

The current price is R$1,677.35.

On which exchange is it traded?

General Electric Company is listed on B3.

What is its stock symbol?

The ticker symbol is GEOO34.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 6.89%.

What is its market cap?

As of today, the market cap is 1.45T.

Has General Electric Company ever had a stock split?

General Electric Company had 1 splits and the recent split was on Aug 02, 2021.

General Electric Company Profile

Consumer Staples Distribution & Retail Industry
Consumer Staples Sector
Mr. Wanyong Lian CEO
B3 Exchange
US3696041033 ISIN
US Country
94,910 Employees
- Last Dividend
2 Aug 2021 Last Split
- IPO Date

Overview

Sinopharm Group Co. Ltd., with its pivotal role outlined within the healthcare sector of the People's Republic of China, operates through its widespread network focusing on the wholesale and retail aspects of pharmaceuticals, medical devices, and various healthcare products. Founded in 2003 and positioned strategically in Shanghai, Sinopharm, through its diversified business model, caters to a comprehensive range of healthcare needs across the nation. It is divided operationally into four primary segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business, ensuring a broad coverage across different healthcare requirements. Beyond the national boundaries, Sinopharm has also established its mark by offering international pharmaceutical and healthcare product manufacturers a host of value-added services including distribution, logistics, and market access services. Notably, Sinopharm Group Co. Ltd. functions under the corporate umbrella of Sinopharm Industrial Investment Co., Ltd., strengthening its corporate synergy and reinforcing its commitment to advancing healthcare access and innovation.

Products and Services

The extensive portfolio of products and services offered by Sinopharm Group Co. Ltd. encapsulates the essence of a comprehensive healthcare provider, attending to a wide spectrum of consumer and business needs within the healthcare industry.

    Pharmaceutical Distribution: Serving as a cornerstone of Sinopharm's offerings, this segment ensures a seamless supply of pharmaceutical products to key stakeholders in the healthcare chain including hospitals, retail pharmacies, clinics, and other distribution channels. Accompanying the distribution are logistics and value-added services catering to both domestic and international markets, aimed at enhancing the efficiency and reach of healthcare solutions.

    Medical Devices: Acknowledging the critical role of technology in modern healthcare, Sinopharm distributes a vast array of medical devices. This initiative bridges the gap between innovative medical technologies and healthcare institutions, thereby facilitating cutting-edge treatments and diagnostics.

    Retail Pharmacy: Through its extensive networks of retail drug stores, which are both owned and franchised, Sinopharm makes healthcare products easily accessible to the general public. This network is a vital component in ensuring community health and wellness by offering a diverse range of pharmaceuticals and related products.

    Other Business Segment: This diverse category includes the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies, further underpining the comprehensiveness of Sinopharm's offerings. Additionally, the group is involved in property management, distribution of Chinese herbal medicines, antibiotics, biological products, and a suite of professional services ranging from IT development, medicine consultation to market research, and project investment management. This amalgamation of services accentuates Sinopharm's integrated approach towards healthcare.

Contact Information

Address: Sinopharm Group Building, Shanghai, China, 200023
Phone: 86 21 2305 2666